Mount Sinai
BostonGene, Mount Sinai Partner on Multiple Myeloma Precision Oncology Study
The study will use BostonGene's assays, including whole-exome and whole-transcriptome sequencing, to inform patients' clinical care and advance drug development.
New York State Awards $3M to Researchers for Infectious Disease Tool Innovations
Teams from Rover Diagnostics, Mount Sinai, Columbia University, and Niagara University are the third round of awardees of the state’s Biodefense Commercialization Fund.
A computationally derived score captured the severity, progression, and underdiagnosis of coronary artery disease.
Population Genetic Screening Would Reveal Patients With Underdiagnosed Disorders, Study Suggests
Researchers developed a data-driven, genomics-first strategy for empirically determining which genes to select for population screening efforts.
Lung Cancer Study Highlights Genetic Variants Involved in Immunosurveillance
Researchers used large-scale population data to link lower-than-usual lung cancer risk to increased heterozygosity in the human leukocyte antigen class II region.